Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Enhanced Group Inc.ENHA · Entity 6262 | Director | October 06, 2026 | October 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Enhanced Group Inc.
Report date October 06, 2026 · Filed October 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 266,188 |
Reported balance
After 2026-10-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-06 · Grant · Acquired 266,188 · Balance 266,188 F1: Each restricted stock unit represents a contingent right to receive one share of Enhanced Group Inc.'s Class A Common Stock. F2: On October 6, 2026, Dr. Han received restricted stock units representing 266,188 shares, vesting in three equal annual installments commencing on the first anniversary of May 8, 2026. As restricted stock units vest, the vested units are automatically converted to vested Class A Common Stock on a one-for-one basis on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Enhanced Group Inc.'s Class A Common Stock.
F2: On October 6, 2026, Dr. Han received restricted stock units representing 266,188 shares, vesting in three equal annual installments commencing on the first anniversary of May 8, 2026. As restricted stock units vest, the vested units are automatically converted to vested Class A Common Stock on a one-for-one basis on the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2026 Filed Oct 8, 2026 23:50 UTC | Enhanced Group Inc. ENHA · Entity 6262 | GrantRestricted Stock Units · Derivative | 266,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-065488 · wk-form4_1791503435.xml · derivative · entry 1 Han Juliette · CIK 0002092550 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,188 Underlying: Class A common stock · 266,188 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Enhanced Group Inc.'s Class A Common Stock. F2 · derivative.exercise_date: On October 6, 2026, Dr. Han received restricted stock units representing 266,188 shares, vesting in three equal annual installments commencing on the first anniversary of May 8, 2026. As restricted stock units vest, the vested units are automatically converted to vested Class A Common Stock on a one-for-one basis on the vesting date. F2 · derivative.expiration_date: On October 6, 2026, Dr. Han received restricted stock units representing 266,188 shares, vesting in three equal annual installments commencing on the first anniversary of May 8, 2026. As restricted stock units vest, the vested units are automatically converted to vested Class A Common Stock on a one-for-one basis on the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.